Page last updated: 2024-10-24

buspirone and Somatoform Disorders

buspirone has been researched along with Somatoform Disorders in 5 studies

Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.

Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)

Research Excerpts

ExcerptRelevanceReference
"Buspirone effectively improves pain and associated psychological symptoms including depressive symptoms, anxiety, somatization, and sleep disturbances in childhood FAP but has no superiority over placebo."9.34Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial. ( Badihian, N; Badihian, S; Saneian, H; Shahsanai, A; Yaghini, O, 2020)
"The aim of this study was to explore the efficacy of buspirone (BSR), in comparison with amitriptyline (AML) in the prophylactic treatment of chronic tension-type headache (CTH), in an open and randomized clinical trial."9.08Buspirone vs amitriptyline in the treatment of chronic tension-type headache. ( Gatzonis, S; Ilias, A; Mitsikostas, DD; Thomas, A, 1997)
"Buspirone effectively improves pain and associated psychological symptoms including depressive symptoms, anxiety, somatization, and sleep disturbances in childhood FAP but has no superiority over placebo."5.34Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial. ( Badihian, N; Badihian, S; Saneian, H; Shahsanai, A; Yaghini, O, 2020)
"The aim of this study was to explore the efficacy of buspirone (BSR), in comparison with amitriptyline (AML) in the prophylactic treatment of chronic tension-type headache (CTH), in an open and randomized clinical trial."5.08Buspirone vs amitriptyline in the treatment of chronic tension-type headache. ( Gatzonis, S; Ilias, A; Mitsikostas, DD; Thomas, A, 1997)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Badihian, N1
Yaghini, O1
Badihian, S1
Shahsanai, A1
Saneian, H1
Phillips, KA3
Hollander, E1
Mitsikostas, DD1
Gatzonis, S1
Thomas, A1
Ilias, A1
Albertini, RS1
Siniscalchi, JM1
Khan, A1
Robinson, M1

Reviews

2 reviews available for buspirone and Somatoform Disorders

ArticleYear
Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.
    Body image, 2008, Volume: 5, Issue:1

    Topics: Body Image; Buspirone; Cognitive Behavioral Therapy; Drug Administration Schedule; Drug Therapy, Com

2008
Pharmacologic treatment of body dysmorphic disorder.
    Psychopharmacology bulletin, 1996, Volume: 32, Issue:4

    Topics: Adult; Buspirone; Humans; Male; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders

1996

Trials

2 trials available for buspirone and Somatoform Disorders

ArticleYear
Comparison of the Efficacy of Buspirone and Placebo in Childhood Functional Abdominal Pain: A Randomized Clinical Trial.
    The American journal of gastroenterology, 2020, Volume: 115, Issue:5

    Topics: Abdominal Pain; Adolescent; Anxiety; Buspirone; Child; Depression; Female; Humans; Male; Pain Measur

2020
Buspirone vs amitriptyline in the treatment of chronic tension-type headache.
    Acta neurologica Scandinavica, 1997, Volume: 96, Issue:4

    Topics: Adult; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Buspirone; Dep

1997

Other Studies

1 other study available for buspirone and Somatoform Disorders

ArticleYear
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:9

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Buspirone; Child; Drug Administ

2001